Cellosaurus logo
expasy logo

Cellosaurus UKF-Rhb-1rOXALI1000 (CVCL_RQ60)

[Text version]
Cell line name UKF-Rhb-1rOXALI1000
Accession CVCL_RQ60
Resource Identification Initiative To cite this cell line use: UKF-Rhb-1rOXALI1000 (RRID:CVCL_RQ60)
Comments Part of: Resistant Cancer Cell Line (RCCL) collection.
Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
Disease Alveolar rhabdomyosarcoma (NCIt: C3749)
Alveolar rhabdomyosarcoma (ORDO: Orphanet_99756)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_4Z17 (UKF-Rhb-1)
Category Cancer cell line
Web pages https://www.wass-michaelislab.org/rccl.php
Publications

PubMed=22170099; DOI=10.1038/cddis.2011.129
Michaelis M., Rothweiler F., Barth S., Cinatl J., van Rikxoort M., Loschmann N., Voges Y., Breitling R., von Deimling A., Rodel F., Weber K., Fehse B., Mack E., Stiewe T., Doerr H.-W., Speidel D., Cinatl J. Jr.
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.
Cell Death Dis. 2:e243.1-e243.8(2011)

Cross-references
Encyclopedic resources Wikidata; Q54990418
Entry history
Entry creation05-Mar-2018
Last entry update29-Jun-2023
Version number6